Baird Financial Group’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,935
| Closed | -$231K | – | 1539 |
|
|
2019
Q2 | $231K | Hold |
3,935
| – | – | ﹤0.01% | 1427 |
|
|
2019
Q1 | $239K | Hold |
3,935
| – | – | ﹤0.01% | 1204 |
|
|
2018
Q4 | $216K | Sell |
3,935
-270
| -6% | -$14.8K | ﹤0.01% | 1197 |
|
|
2018
Q3 | $269K | Sell |
4,205
-935
| -18% | -$59.8K | ﹤0.01% | 1205 |
|
|
2018
Q2 | $303K | Sell |
5,140
-255
| -5% | -$15K | ﹤0.01% | 1138 |
|
|
2018
Q1 | $307K | Sell |
5,395
-250
| -4% | -$14.2K | ﹤0.01% | 1120 |
|
|
2017
Q4 | $335K | Sell |
5,645
-185
| -3% | -$11K | ﹤0.01% | 1110 |
|
|
2017
Q3 | $337K | Sell |
5,830
-1,895
| -25% | -$110K | ﹤0.01% | 1080 |
|
|
2017
Q2 | $456K | Sell |
7,725
-290
| -4% | -$17.1K | ﹤0.01% | 986 |
|
|
2017
Q1 | $442K | Sell |
8,015
-3,600
| -31% | -$199K | ﹤0.01% | 981 |
|
|
2016
Q4 | $610K | Buy |
11,615
+40
| +0.3% | +$2.1K | 0.01% | 876 |
|
|
2016
Q3 | $665K | Hold |
11,575
| – | – | 0.01% | 860 |
|
|
2016
Q2 | $704K | Sell |
11,575
-760
| -6% | -$46.2K | 0.01% | 841 |
|
|
2016
Q1 | $709K | Buy |
12,335
+180
| +1% | +$10.3K | 0.01% | 823 |
|
|
2015
Q4 | $794K | Sell |
12,155
-6,200
| -34% | -$405K | 0.01% | 768 |
|
|
2015
Q3 | $1.16M | Hold |
18,355
| – | – | 0.01% | 663 |
|
|
2015
Q2 | $1.3M | Buy |
+18,355
| New | +$1.3M | 0.01% | 670 |
|